Bibliometric Analysis
Journal Bibliometric Report (2021)
The Journal Bibliometric Report is based on all publications in Medline/Pubmed that were cited by Medline/Pubmed publications in 2021.
Journals for Antineoplastic Agents
For each journal, the table below lists the year of the most recent citable publication (Last Year); the total number of times citable publications were cited in 2021 (Total Cites); the average number of times citable publications from 2019 and 2020 were cited by publications in 2021 (Impact Factor); the average number of times citable publications from 2016 through 2020 were cited by publications in 2021 (5-Year Impact); the average number of times citable publications from 2021 were cited by publications in 2021 (Immediacy Index); the number of citable publications in 2021 (Articles); and the median age in years of citable publications that were cited by publications in 2021 (Cited Half-Life). Citable publications are those whose Medline/Pubmed type is "Journal Article", which in general includes things like original research, meta-analysis, and reviews, but does not include editorials or letters. The data in the table below includes self-citations.
| Rank | Journal | Last Year | Total Cites | Impact Factor | 5-Year Impact | Immediacy Index | Articles | CitedHalfLife | JournalDetails |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Anticancer Agents Med Chem | 2026 | 2496 | 1.069 | 1.197 | 0.605 | 238 | 5 | Details |
| 2 | Anticancer Drug Des | 2001 | 88 | 0.000 | 0.000 | 0.000 | 0 | 25 | Details |
| 3 | Anticancer Drugs | 2026 | 2671 | 1.368 | 1.381 | 0.787 | 141 | 7 | Details |
| 4 | Cancer Biother | 1995 | 17 | 0.000 | 0.000 | 0.000 | 0 | 27 | Details |
| 5 | Cancer Chemother Pharmacol | 2026 | 7086 | 2.084 | 2.160 | 0.481 | 162 | 8 | Details |
| 6 | Cancer Chemother Rep 2 | 1974 | 4 | 0.000 | 0.000 | 0.000 | 0 | 47 | Details |
| 7 | Cancer Chemother Rep 3 | 1974 | 9 | 0.000 | 0.000 | 0.000 | 0 | 48 | Details |
| 8 | Cancer Drug Deliv | 1987 | 16 | 0.000 | 0.000 | 0.000 | 0 | 37 | Details |
| 9 | Cancer Treat Rep | 1987 | 417 | 0.000 | 0.000 | 0.000 | 0 | 40 | Details |
| 10 | Cancer Treat Rev | 2026 | 8044 | 8.799 | 7.931 | 1.292 | 106 | 5 | Details |
| 11 | Chemioterapia | 1988 | 12 | 0.000 | 0.000 | 0.000 | 0 | 36 | Details |
| 12 | Curr Cancer Drug Targets | 2026 | 2425 | 1.770 | 2.190 | 0.729 | 70 | 8 | Details |
| 13 | Curr Med Chem Anticancer Agents | 2005 | 218 | 0.000 | 0.000 | 0.000 | 0 | 17 | Details |
| 14 | Drug Resist Updat | 2026 | 2843 | 13.409 | 12.280 | 2.381 | 21 | 6 | Details |
| 15 | Gan To Kagaku Ryoho | 2026 | 660 | 0.062 | 0.064 | 0.006 | 544 | 9 | Details |
| 16 | Invest New Drugs | 2026 | 3829 | 2.278 | 2.371 | 0.474 | 156 | 6 | Details |
| 17 | J Chemother | 2026 | 1023 | 1.167 | 1.101 | 0.289 | 83 | 8 | Details |
| 18 | Mol Cancer Ther | 2026 | 16613 | 3.849 | 4.739 | 0.748 | 214 | 7 | Details |
| 19 | Sel Cancer Ther | 1991 | 4 | 0.000 | 0.000 | 0.000 | 0 | 30 | Details |


